Novo Nordisk's Ozempic and Wegovy now available in U.S.

Ozempic, Wegovy move closer to no longer being in shortage, FDA says
After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list. The change in status comes nearly six months after Novo Nordisk,
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.
Ozempic and Wegovy considered ‘available’ after more than 2 years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA). While the drugs remain on the shortage list for now ...
FDA Says All Doses of Novo’s Ozempic, Wegovy Now Available
Wednesday’s update to the regulator’s drug shortage database is good news for Novo Nordisk, which has struggled to keep up with demand for the blockbuster GLP-1 drugs.
Novo takes big step toward ending Ozempic, Wegovy shortages
All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned patients may still experience "variability" filling their prescriptions.
Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage - Demand for the popular weight loss and diabetes drugs has spiked dramatically in recent years
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage at various times.
Medpage Today on MSN20h
Wegovy Reduced Pain From Knee Osteoarthritis
Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
ConsumerAffairs13d
Ozempic vs. Wegovy: Which is best for weight loss?
FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...
MedPage Today on MSN2d
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD
Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN ...
Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections
As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...
STAT3h
Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more
All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...
7 common myths about semaglutide and weight loss debunked
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug are primarily used for managing diabetes. However, some doctors prescribe ...